Respiratory Tract and Mediastinum 2

Total Page:16

File Type:pdf, Size:1020Kb

Respiratory Tract and Mediastinum 2 Respiratory Tract and Mediastinum 2 2.1 Respiratory Tract, FNAB and Exfoliative Cytology: Introduction, Normal and Abnormal Cells, Non-cellular Components, Respiratory Infections . 107 2 .1 .1 Introduction . 107 2 .1 .2 Cell Lining of the Respiratory System and Cell Function . 109 2 .1 .3 Normal Cytology and Benign Cellular Components . 110 2 .1 .4 Abnormal and Atypical Epithelial Cells . 112 2 .1 .5 Endogenous and Exogenous Noncellular Elements and Nonhuman Cellular Components . 115 2 .1 .6 Infectious Diseases . 116 2 .1 .7 Further Reading . 118 2.2 Respiratory Tract, FNAB and Exfoliative Cytology: Tumor-like Lesions, Benign and Malignant Tumors . 134 2 .2 .1 Benign Tumors and Pseudotumorous Lesions of the Lung (Selected Entities) . 134 2 .2 .2 Malignant Tumors of the Lung . 138 2 .2 .3 Neuroendocrine Tumors . 149 2 .2 .4 Further Reading . 152 2.3 Respiratory Tract: Bronchoalveolar Lavage . 176 2 .3 .1 Introduction . 176 2 .3 .2 Laboratory Procedures, Technical Aspects, Reporting . 176 2 .3 .3 Normal Cytology in BAL Specimens . 178 2 .3 .4 Diagnostic Findings in BAL Specimens . 178 2 .3 .5 Infectious Diseases . 187 2 .3 .6 Malignancies . 188 2 .3 .7 Other Pulmonary Disorders with Particular BAL Cytology . 189 2 .3 .8 Bronchoalveolar Lavage in Lung Transplant Recipients . 190 2 .3 .9 Further Reading . 191 Spieler/Rössle, Nongynecologic Cytopathology. A Practical Guide. Essentials of Diagnostic Pathology, DOI 10.1007/978-3-642-24719-4_2, © Springer-Verlag Berlin Heidelberg 2012 2.4 Mediastinum: Introduction, Non-tumorous and Neoplastic Disorders, Thymus Gland and its Diseases . 204 2 .4 .1 Introduction . 204 2 .4 .2 Cytology of Nontumorous Mediastinal Disorders . 206 2 .4 .3 Thymus Gland and Its Diseases . 208 2 .4 .4 Neurogenic Tumors and Mesenchymal Tumors . 216 2 .4 .5 Miscellaneous Lesions . 217 2 .4 .6 Metastases to the Thymus and Mediastinum . 217 2 .4 .7 Further Reading . 218 Synopsis and Algorithms 2.1 Respiratory Tract, FNAB and Exfoliative Cytology: Normal and Abnormal Cells, Granulomatous and Infectious Diseases . 1124 2.2 Respiratory Tract, FNAB and Exfoliative Cytology: Tumor-like Lesions, Benign and Malignant Tumors . 1129 2.4 Mediastinum: Non-tumorous Lesions, Thymus Gland and its Diseases, Lymphoid Disorders . 1138 107 Section 2.1 Respiratory Tract: FNAB and Exfoliative Cytology Introduction Normal and Abnormal Cells Noncellular Components Respiratory Infections 2.1.1 Introduction 2.1.1.1 Cytopreparatory Methods General Comments 2.1.1.1.1 Paraffin Embedding zz During the past few decades, the investigation of cyto- Paraffin embedding of sputum [110] for histologic work-up logic samples from the lower respiratory tract has been was abandoned many years ago. However, the method established in major hospitals, pulmonary clinics, and to- known as the cell-block technique is still in use for cell mate- gether with chest physicians’ offices throughout the world. rial sampled by FNAB and, sporadically, for tissue frag- zz It has become a common tool in diagnostic evaluation of ments or clots from exfoliative specimens as well. any patient with suspected lung cancer, particular infec- tious diseases, and interstitial lung disorders. Further- 2.1.1.1.2 Cell-Freeing Techniques more, in recent years fine-needle aspiration biopsy Techniques for cell freeing and tumor cell concentrating by (FNAB) has greatly enhanced the impact of cytology on mucolysis are valuable methods, but they appear to be too primary lung cancer diagnosis and tumor staging. laborious and time-consuming in daily practice [11, 53]. zz This section covers: (1) The important technical aspects of pulmonary cytolo- 2.1.1.1.3 Major Techniques gy. The major techniques include: the wet-film preparation, the (2) The cytology of exfoliative bronchial and alveolar pick-and-smear technique from fresh or prefixed respiratory samples. exfoliative material, the Saccomanno blender technique, and (3) Transthoracic, transbronchial, transesophageal FNAB the membrane filtration techniques [14, 23, 94]. These four for diagnosing primary and metastatic lung tumors, methods may be used for spontaneously produced or induced and mediastinal lesions. sputum, bronchial washings and brushings, bronchoalveolar (4) Cytologically relevant primary mediastinal pathologic lavage, and fine-needle aspirates. conditions. Pick-and-smear from fresh unfixed respiratory material. zz Numerous reviews, monographs, and textbooks are This technique generally yields sufficient diagnostic material available covering all aspects pertaining to pulmonary cy- along with excellent preservation and staining of the cells. tology. The method is highly appreciated at our institution. Fresh early-morning deep-cough specimen of sputum is collected and submitted in a wide-mouthed jar. In the laboratory the specimen is poured into a Petri dish and dispersed for inspec- tion. The mass is examined for grey-white smooth strings of mucus and blood-tinged areas that have been found to most 108 Chapter 2 Respiratory Tract and Mediastinum likely harbor tumor cells. Samples are picked from the se- duction of fiberoptic bronchoscopy and the wide use of 1 lected areas and gently crush-smeared between two glass FNAB, sputum cytology has diminished [58]. Pulmonologists slides. The smears are immediately placed in 95% ethyl alco- and institutions specialized in lung diseases prefer primary 2 hol or Delauney’s solution for 15–30 min. investigation using invasive and more directed methods based upon imaging results and supported by auxiliary device. Caution The selection of blood-tinged and/or gray-white mucus 2.1.1.2.1 Sputum: Spontaneous and Induced, strings is critical in correct processing of fresh deep- and Postbronchoscopy Sputum cough sputum specimens Sputum specimens are prepared as described. In patients who cannot produce sputum by deep coughing, a sputum sample may be induced by inhalation of an aerosolized solu- Pick-and-smear from prefixed respiratory material. Prefixed tion [72, 80]. The vapor stimulates mucus production and sputum may be obtained in situations where it is not possible may enhance the coughing stimulus. Another useful physical to transmit fresh, unfixed material to the laboratory. The pa- technique for provoked expectoration is the external percus- tient expectorates into a jar partially filled with 70% ethyl sion and vibration of the chest wall [96]. Postbronchoscopy alcohol. The disadvantage of this procedure is insufficient sputum is an approach used to increase diagnostic accuracy. preservation and poor staining quality of the cells trapped in However, from our experience, a high percentage of post- masses of mucus that is penetrated by the fixative and dye bronchoscopy samples are extremely sanguineous and diffi- with difficulty. cult to evaluate. Saccomanno blender technique. This technique for homog- enization and cell concentration is used for sputum speci- Caution mens collected in Saccomanno fixative [81]. While in Eu- Deep-cough specimens and their immediate transfer to rope the technique is less accepted, it has gained wide the cytology laboratory after collecting are of utmost popularity particularly in the United States and on other con- importance for reliable diagnostic results . tinents. The method produces artifacts on tumor cells that may impair diagnostic accuracy compared to slide prepara- tions from unfixed sputum samples [73]. 2.1.1.2.2 Bronchial Aspirates, Washings, and Brushing 2.1.1.1.4 Special Techniques The development of the flexible fiberoptic bronchoscope has The bronchial brush direct smear preparation. The mucus- enabled the operator to reach much smaller bronchi com- rich material adherent to a brush is smeared by rolling the pared to those formerly attained by the rigid bronchoscope. brush over one or more glass slides followed by immediate Specimens are obtained from the periphery of the bron- fixation. This method should only be used by skilled bron- chial tree by: choscopists or an attendant cytotechnologist. − Aspiration of localized secretions. Cytocentrifugation is particularly applied to process lavage − Instilling a few milliliters of a saline solution through the fluids. bronchoscope and re-aspiration of the fluid together with Liquid-based cytology is increasingly used for the process- the exfoliated cells. ing of FNAB material [103]. The advantages and interpreta- − Brushing a conspicuous lesion with a brush inserted tive cautions concerning the liquid-based preparation are re- through the endoscope. ported in the literature [75] and in various chapters of this work (e.g., Sect. 10.1.2.2, p. 634). Laboratory procedures and technical aspects concerning bronchoalveolar lavage (BAL) are discussed in Sect. 2.3.2, 2.1.1.1.5 Staining p. 176. The Papanicolaou (Pap) method is the most widely accepted Aspirates and washings, and brush samples rinsed in an staining method for cytologic preparations of respiratory appropriate solution (balanced salt solution or cell medium) specimens. are to be centrifuged. Subsequently, smears are prepared from the cell button. The different preparation techniques in- cluding bronchial brush direct smear preparation have been 2.1.1.2 Sampling Modalities described above. Presence of blood in aspirates and brushings is frequent The accuracy of the different modalities as to cancer diagno- and found most particularly in patients with primary lung sis has recently been summarized from published data by cancer involving the bronchial system. Vigorous brushing Schreiber and McCrory [84]. may provide large tissue fragments
Recommended publications
  • General Pathomorpholog.Pdf
    Ukrаiniаn Medicаl Stomаtologicаl Аcаdemy THE DEPАRTАMENT OF PАTHOLOGICАL АNАTOMY WITH SECTIONSL COURSE MАNUАL for the foreign students GENERАL PАTHOMORPHOLOGY Poltаvа-2020 УДК:616-091(075.8) ББК:52.5я73 COMPILERS: PROFESSOR I. STАRCHENKO ASSOCIATIVE PROFESSOR O. PRYLUTSKYI АSSISTАNT A. ZADVORNOVA ASSISTANT D. NIKOLENKO Рекомендовано Вченою радою Української медичної стоматологічної академії як навчальний посібник для іноземних студентів – здобувачів вищої освіти ступеня магістра, які навчаються за спеціальністю 221 «Стоматологія» у закладах вищої освіти МОЗ України (протокол №8 від 11.03.2020р) Reviewers Romanuk A. - MD, Professor, Head of the Department of Pathological Anatomy, Sumy State University. Sitnikova V. - MD, Professor of Department of Normal and Pathological Clinical Anatomy Odessa National Medical University. Yeroshenko G. - MD, Professor, Department of Histology, Cytology and Embryology Ukrainian Medical Dental Academy. A teaching manual in English, developed at the Department of Pathological Anatomy with a section course UMSA by Professor Starchenko II, Associative Professor Prylutsky OK, Assistant Zadvornova AP, Assistant Nikolenko DE. The manual presents the content and basic questions of the topic, practical skills in sufficient volume for each class to be mastered by students, algorithms for describing macro- and micropreparations, situational tasks. The formulation of tests, their number and variable level of difficulty, sufficient volume for each topic allows to recommend them as preparation for students to take the licensed integrated exam "STEP-1". 2 Contents p. 1 Introduction to pathomorphology. Subject matter and tasks of 5 pathomorphology. Main stages of development of pathomorphology. Methods of pathanatomical diagnostics. Methods of pathomorphological research. 2 Morphological changes of cells as response to stressor and toxic damage 8 (parenchimatouse / intracellular dystrophies).
    [Show full text]
  • Of the Pediatric Mediastinum
    MRI of the Pediatric Mediastinum Dianna M. E. Bardo, MD Director of Body MR & Co-Director of the 3D Innovation Lab Disclosures Consultant & Speakers Bureau – honoraria Koninklijke Philips Healthcare N V Author – royalties Thieme Publishing Springer Publishing Mediastinum - Anatomy Superior Mediastinum thoracic inlet to thoracic plane thoracic plane to diaphragm Inferior Mediastinum lateral – pleural surface anterior – sternum posterior – vertebral bodies Mediastinum - Anatomy Anterior T4 Mediastinum pericardium to sternum Middle Mediastinum pericardial sac Posterior Mediastinum vertebral bodies to pericardium lateral – pleural surface superior – thoracic inlet inferior - diaphragm Mediastinum – MR Challenges Motion Cardiac ECG – gating/triggering Breathing Respiratory navigation Artifacts Intubation – LMA Surgical / Interventional materials Mediastinum – MR Sequences ECG gated/triggered sequences SSFP – black blood SE – IR – GRE Non- ECG gated/triggered sequences mDIXON (W, F, IP, OP), eTHRIVE, turbo SE, STIR, DWI Respiratory – triggered, radially acquired T2W MultiVane, BLADE, PROPELLER Mediastinum – MR Sequences MRA / MRV REACT – non Gd enhanced Gd enhanced sequences THRIVE, mDIXON, mDIXON XD Mediastinum – Contents Superior Mediastinum PVT Left BATTLE: Phrenic nerve Vagus nerve Structures at the level of the sternal angle Thoracic duct Left recurrent laryngeal nerve (not the right) CLAPTRAP Brachiocephalic veins Cardiac plexus Aortic arch (and its 3 branches) Ligamentum arteriosum Thymus Aortic arch (inner concavity) Trachea Pulmonary
    [Show full text]
  • Clinical Case
    Annals of Oncology 9: 95-100. 1998. © 1998 Kluwer Academic Publishers. Printed in the Netherlands. Clinical case Management of an isolated thymic mass after primary therapy for lymphoma S. Anchisi, R. Abele, M. Guetty-Alberto & P. Alberto Division of Oncology, Department of Medicine, University Hospital, Geneva, Switzerland Key words: CT scan, galliumscintigraphy, Hodgkin's disease, lymphoma, residual mass, thymus hyperplasia Introduction pose tissue constituting less than 40% of the total mass. The patient is still in CR 51 months after the end of The appearance of an anterior mediastinal mass during treatment. the follow-up of patients successfully treated for lym- phoma is worrisome, and may suggest treatment failure. Case 2 However, benign 'rebound' thymic hyperplasia (TH), a well documented phenomenon in children [1-3] and in A 26-year-old woman presented with a stage IVB young adults treated for malignant testicular teratoma nodular sclerosing HD, with liver and spleen infiltration [4], is an important differential diagnosis even in the and a bulky mediastinum. adult population [5]. Magnetic resonance imaging (MRI) disclosed a dif- fuse infiltration of the thoracic and lumbar vertebral bodies. The result of a bone-marrow biopsy was normal. Case reports Five courses of VEMP chemotherapy (vincristine, eto- poside, mitoxantrone, prednisone) produced a partial Between July 1990 and December 1994, we observed response greater than 75%. The treatment was intensi- two cases of TH among 58 adults treated consecutively fied with a BEAM chemotherapy (carmustine, etoposide, at our institution. Thirty of the 58 had de novo Hodgkin's cytosine arabinoside, melphalan), followed by an autol- disease (HD) and 28 had aggressive non-Hodgkin's ogous bone marrow transplant (BMT).
    [Show full text]
  • Preventing Thymus Involution in K5.Cyclin D1 Transgenic Mice Sustains the Naïve T Cell Compartment with Age
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2015 PREVENTING THYMUS INVOLUTION IN K5.CYCLIN D1 TRANSGENIC MICE SUSTAINS THE NAÏVE T CELL COMPARTMENT WITH AGE Michelle L. Bolner Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Cell Biology Commons, Immunology and Infectious Disease Commons, Molecular Biology Commons, and the Molecular Genetics Commons Recommended Citation Bolner, Michelle L., "PREVENTING THYMUS INVOLUTION IN K5.CYCLIN D1 TRANSGENIC MICE SUSTAINS THE NAÏVE T CELL COMPARTMENT WITH AGE" (2015). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 636. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/636 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. PREVENTING THYMUS INVOLUTION IN K5.CYCLIN D1 TRANSGENIC MICE SUSTAINS THE NAÏVE T CELL COMPARTMENT WITH AGE BY Michelle Lynn Bolner, Ph.D. Candidate APPROVED: _____________________________________ Ellen R. Richie, Ph.D., Supervisory Professor _____________________________________ Shawn B. Bratton, Ph.D. _____________________________________ David G. Johnson, Ph.D.
    [Show full text]
  • Rebound Thymic Hyperplasia After Chemotherapy in Children
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE + MODEL provided by Elsevier - Publisher Connector Pediatrics and Neonatology (2016) xx,1e7 Available online at www.sciencedirect.com ScienceDirect journal homepage: http://www.pediatr-neonatol.com ORIGINAL ARTICLE Rebound Thymic Hyperplasia after Chemotherapy in Children with Lymphoma Chih-Ho Chen a, Chih-Chen Hsiao a, Yu-Chieh Chen a, Sheung-Fat Ko b, Shu-Hua Huang c, Shun-Chen Huang d, Kai-Sheng Hsieh a, Jiunn-Ming Sheen a,* a Department of Pediatrics, Chang Gung Memorial HospitaldKaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan b Department of Radiology, Chang Gung Memorial HospitaldKaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan c Department of Nuclear Medicine, Chang Gung Memorial HospitaldKaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan d Department of Pathology, Chang Gung Memorial HospitaldKaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan Received Sep 24, 2015; received in revised form Nov 30, 2015; accepted Feb 5, 2016 Available online --- Key Words Background: Development of mediastinal masses after completion of chemotherapy in pediat- lymphoma; ric patients with malignant lymphoma is worrisome and challenging to clinicians. prognosis; Methods: We performed a retrospective review of 67 patients with lymphoma treated at our rebound thymic hospital from January 1, 2001 to June 1, 2013. Patients who received at least two chest hyperplasia; computed tomography (CT) examinations after complete remission (CR) was achieved were recurrence further analyzed. Gallium-67 scans and positron emission tomography (PET) were recorded and compared between these patients.
    [Show full text]
  • Normative Values of Thymus in Healthy Children; Stiffness by Shear Wave Elastography
    Diagn Interv Radiol 2020; 26:147–152 PEDIATRIC RADIOLOGY © Turkish Society of Radiology 2020 ORIGINAL ARTICLE Normative values of thymus in healthy children; stiffness by shear wave elastography Zuhal Bayramoğlu PURPOSE Mehmet Öztürk Thymus grows after birth, reaches maximal size after the first few years and involutes by puber- Emine Çalışkan ty. Because of the postnatal developmental and involutional duration, we aimed to investigate normal stiffness values of mediastinal thymus by shear wave elastography (SWE) in different age Hakan Ayyıldız groups of children and discuss imaging findings of thymus. İbrahim Adaletli METHODS We prospectively examined 146 children (90 girls, 56 boys) who underwent a thyroid or neck ultrasound examination. All subjects underwent ultrasound and SWE evaluation of mediastinal thymus by parasternal and suprasternal approach. We grouped the subjects based on age as 0 to 2 months, >2 to 6 months, >6 months to 2 years, >2 to 5 years, >5 to 8 years, and greater than 8 years old. We investigated differences of mean shear wave elasticity (kPa) and shear wave veloc- ity (m/s) values among age groups and the association of SWE values with age, body mass index (BMI), height, and weight of the patients. RESULTS Median and range of age, height, weight, and BMI were 24 months (2–84 months), 85 cm (55– 120 cm), 12 kg (4.55–22 kg), 15.37 kg/m2 (13.92–17.51 kg/m2), 11 cc (2.64–23.15 cc), respectively. Mean shear wave elasticity of thymus of all participants was 6.76±1.04 kPa. Differences of mean elasticity values among the age and gender groups were not statistically significant.
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • The Mediastinum—Is It Wide? Emerg Med J: First Published As 10.1136/Emj.18.3.183 on 1 May 2001
    Emerg Med J 2001;18:183–185 183 The mediastinum—Is it wide? Emerg Med J: first published as 10.1136/emj.18.3.183 on 1 May 2001. Downloaded from C E Gleeson, R L Spedding, L A Harding, M Caplan Abstract Objective—To determine if the 8 cm upper limit for mediastinal width applies in the trauma setting of today. To define the upper limit of normal mediastinal width for supine chest films. Methods—A retrospective review of chest computed tomography scans was con- ducted to determine the width and posi- tion of the mediastinum within the supine chest. Radiographs were performed using a model that enabled the degree of mediastinal magnification to be ascer- tained in a variety of clinical settings. Figure 1 CT scan of the chest at the level of the aortic Results—The mean mediastinal width is arch. 6.31 cm. With standard radiographical techniques this mediastinum is magnified where pathology distorted the mediastinum to 8.93–10.07 cm. With minor adaptations were excluded. The remaining scans were then in radiographical technique this can be examined at the level of the maximum reduced to 7.31–7.92 cm. diameter of the aortic arch to determine: Conclusion—The 8 cm upper limit for (1) The composition and transverse diameter normal mediastinal width, set in the 1970s of the mediastinum at this level. does not apply in the modern trauma (2) The maximum width of the aortic arch. room. Changes in the position of the x ray (3) The distance from the anterior surface of cassette, and lengthening of the distance the aortic arch to the skin of the posterior between the patient and the x ray source chest wall.
    [Show full text]
  • CT-Based Mediastinal Compartment Classifications and Differential
    Japanese Journal of Radiology (2019) 37:117–134 https://doi.org/10.1007/s11604-018-0777-5 INVITED REVIEW CT‑based mediastinal compartment classifcations and diferential diagnosis of mediastinal tumors Takahiko Nakazono1 · Ken Yamaguchi1 · Ryoko Egashira1 · Yukari Takase2 · Junichi Nojiri1 · Masanobu Mizuguchi1 · Hiroyuki Irie1 Received: 16 July 2018 / Accepted: 10 September 2018 / Published online: 20 September 2018 © Japan Radiological Society 2018 Abstract Division of the mediastinum into compartments is used to help narrow down the diferential diagnosis of mediastinal tumors, assess tumor growth, and plan biopsies and surgical procedures. There are several traditional mediastinal compartment classifcation systems based upon anatomical landmarks and lateral chest radiograph. Recently, the Japanese Association of Research of the Thymus (JART) and the International Thymic Malignancy Interest Group (ITMIG) proposed new mediastinal compartment classifcation systems based on transverse CT images. These CT-based classifcation systems are useful for more consistent and exact diagnosis of mediastinal tumors. In this article, we review these CT-based mediastinal compart- ment classifcations in relation to the diferential diagnosis of mediastinal tumors. Keywords Mediastinum · Compartment · Computed tomography · Magnetic resonance imaging Introduction have resulted in confusion among physicians. In addition, the traditional models are based on lateral chest radiographs, The mediastinum is anatomically bound on the lateral side and thus some mediastinal lesions cannot be reliably local- by the parietal pleural refections along the medial aspects ized to a specifc compartment, since considerable overlap of both lungs, superiorly by the thoracic inlet, inferiorly by exists among the radiographically imaged compartments. the diaphragm, anteriorly by the sternum, and posteriorly Because mediastinal lesions are optimally evaluated with by the thoracic vertebral bodies.
    [Show full text]
  • Superior and Posterior Mediastina Reading: 1. Gray's Anatomy For
    Dr. Weyrich G07: Superior and Posterior Mediastina Reading: 1. Gray’s Anatomy for Students, chapter 3 Objectives: 1. Subdivisions of mediastinum 2. Structures in Superior mediastinum 3. Structures in Posterior mediastinum Clinical Correlate: 1. Aortic aneurysms Superior Mediastinum (pp.181-199) 27 Review of the Subdivisions of the Mediastinum Superior mediastinum Comprises area within superior thoracic aperture and transverse thoracic plane -Transverse thoracic plane – arbitrary line from the sternal angle anteriorly to the IV disk or T4 and T5 posteriorly Inferior mediastinum Extends from transverse thoracic plane to diaphragm; 3 subdivisions Anterior mediastinum – smallest subdivision of mediastinum -Lies between the body of sternum and transversus thoracis muscles anteriorly and the pericardium posteriorly -Continuous with superior mediastinum at the sternal angle and limited inferiorly by the diaphragm -Consists of sternopericardial ligaments, fat, lymphatic vessels, and branches of internal thoracic vessels. Contains inferior part of thymus in children Middle mediastinum – contains heart Posterior mediastinum Superior Mediastinum Thymus – lies posterior to manubrium and extends into the anterior mediastinum -Important in development of immune system through puberty -Replaced by adipose tissue in adult Arterial blood supply -Anterior intercostals and mediastinal branches of internal thoracic artery Venous blood supply -Veins drain into left brachiocephalic, internal thoracic, and thymic veins 28 Brachiocephalic Veins - Formed by the
    [Show full text]
  • ICD–9–CM Codes Denied
    Federal Register / Vol. 66, No. 226 / Friday, November 23, 2001 / Rules and Regulations 58837 Code Description 999.2 ................................................................. Other vascular complications 999.8 ................................................................. Other transfusion reactions V08 ................................................................... Asymptomatic HIV infection V12.1 ................................................................ History of nutritional deficiency V12.3 ................................................................ Personal history of diseases of blood and blood-forming organs V12.50–V12.59 ................................................. Diseases of circulatory system V15.1 ................................................................ Personal history of surgery to heart and great vessels V15.2 ................................................................ Personal history of surgery of other major organs V42.0 ................................................................ Kidney replaced by transplant V42.1 ................................................................ Heart replaced by transplant V42.2 ................................................................ Heart valve replaced by transplant V42.6 ................................................................ Lung replaced by transplant V42.7 ................................................................ Liver replaced by transplant V42.8 ...............................................................
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2007/0292883 A1 Ossovskaya Et Al
    US 20070292883A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2007/0292883 A1 Ossovskaya et al. (43) Pub. Date: Dec. 20, 2007 (54) METHOD OF TREATING DISEASES WITH (52) U.S. Cl. ............................. 435/6: 435/723: 514/394; PARP INHIBITORS 514/543; 514/309; 514/312: 435/91.2: 514/415: 514/457 (76) Inventors: Valeria S. Ossovskaya, San Francisco, CA (US); Barry M. Sherman, Hillsborough, CA (US) (57) ABSTRACT Correspondence Address: SSSSSS(pDRICH & ROSAT The present invention relates to methods of identifying a PALO ALTO, CA 94304-1050 (US) disease treatable with PARP modulators by identifying a 9 level of PARP in a sample of a subject, making a decision (21) Appl. No.: 11/818,210 regarding identifying the disease treatable by the PARP modulators wherein the decision is made based on the level (22) Filed: Jun. 12, 2007 of PARP. The method further comprises of treating the O O disease in the subject with the PARP modulators. The Related U.S. Application Data methods relate to identifying up-regulated PARP in a disease (60) Provisional application No. 60/804,563, filed on Jun. and making a decision regarding the treatment of the disease 12, 2006. Provisional application No. 60/866,602, with PARP inhibitors. The extent of PARP up-regulation in filed on Nov. 20, 2006. a disease can also help in determining the efficacy of the treatment with PARP inhibitors. The present invention dis Publication Classification closes various diseases that have up-regulated or down regulated PARP and can be treated with PARP inhibitors or (51) , C.
    [Show full text]